LigaChem Biosciences Inc. (KOSDAQ:141080)
South Korea
· Delayed Price · Currency is KRW 194,500
-9,000 (-4.42%)
Apr 29, 2026, 3:30 PM KST
LigaChem Biosciences Revenue
In the year 2025, LigaChem Biosciences had annual revenue of 141.55B KRW with 12.43% growth. LigaChem Biosciences had revenue of 15.95B in the quarter ending December 31, 2025, a decrease of -52.62%.
Revenue
141.55B
Revenue Growth
+12.43%
P/S Ratio
50.07
Revenue / Employee
832.67M
Employees
170
Market Cap
7,087.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 141.55B | 15.65B | 12.43% |
| Dec 31, 2024 | 125.90B | 91.75B | 268.71% |
| Dec 31, 2023 | 34.15B | 733.60M | 2.20% |
| Dec 31, 2022 | 33.41B | 1.26B | 3.90% |
| Dec 31, 2021 | 32.16B | -25.34B | -44.07% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SK Biopharmaceuticals | 706.74B |
| Peptron | 5.63B |
| HLB Co., Ltd. | 84.17B |
| Kolon TissueGene | 5.16B |
| Voronoi | 7.51B |
| OliX Pharmaceuticals | 14.67B |
| Samsung Epis Holdings | 1,510.14B |
| SK bioscience | 651.37B |